| Year |
Citation |
Score |
| 2024 |
Arnhold V, Chang WY, Jansen SA, Thangavelu G, Calafiore M, Vinci P, Fu YY, Ito T, Takashima S, Egorova A, Kuttiyara J, Perlstein A, van Hoesel M, Liu C, Blazar BR, ... ... Hanash AM, et al. Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage. The Journal of Clinical Investigation. PMID 38349762 DOI: 10.1172/JCI155880 |
0.304 |
|
| 2023 |
DeWolf S, Elhanati Y, Nichols K, Waters NR, Nguyen CL, Slingerland JB, Rodriguez N, Lyudovyk O, Giardina PA, Kousa AI, Andrlová H, Ceglia N, Fei T, Kappagantula R, Li Y, ... ... Hanash AM, et al. Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse. Science Translational Medicine. 15: eabq0476. PMID 37494469 DOI: 10.1126/scitranslmed.abq0476 |
0.382 |
|
| 2023 |
Jansen SA, Cutilli A, de Koning C, van Hoesel M, Sierra LS, Nierkens S, Mokry M, Nieuwenhuis EES, Hanash AM, Mocholi E, Coffer PJ, Lindemans CA. Chemotherapy-induced intestinal injury promotes Galectin-9-driven modulation of T cell function. Biorxiv : the Preprint Server For Biology. PMID 37163028 DOI: 10.1101/2023.04.30.538862 |
0.426 |
|
| 2022 |
Jansen SA, Nieuwenhuis EES, Hanash AM, Lindemans CA. Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunology. PMID 35654837 DOI: 10.1038/s41385-022-00527-6 |
0.362 |
|
| 2020 |
Barker JN, Devlin SM, Naputo KA, Skinner K, Maloy MA, Flynn L, Anagnostou T, Avecilla ST, Scaradavou A, Cho C, Dahi PB, Giralt SA, Gyurkocza B, Hanash AM, Hsu K, et al. High progression-free survival after intermediate intensity double unit cord blood transplantation in adults. Blood Advances. 4: 6064-6076. PMID 33290545 DOI: 10.1182/bloodadvances.2020003371 |
0.367 |
|
| 2020 |
Ponce DM, Alousi AM, Nakamura R, Sandhu KS, Barker JN, Shia J, Yan X, Daley WL, Moore G, Fatmi S, Soto C, Gomes A, Slingerland J, Giardina P, Peled JU, ... ... Hanash AM, et al. A Phase 2 Study of F-652, a Novel Tissue-Targeted Recombinant Human Interleukin-22 (IL-22) Dimer, for Treatment of Newly Diagnosed Acute Gvhd of the Lower GI Tract Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.124 |
0.344 |
|
| 2020 |
Politikos I, Maloy MA, Devlin SM, Naputo K, Bhatt V, Skinner K, Cho C, Dahi PB, Giralt SA, Gyurkocza B, Hanash AM, Jakubowski AA, Papadopoulos EB, Perales M, Peled JU, et al. Addition of Tocilizumab to Cyclosporine-a/ Mycophenolate Mofetil (CSA/ MMF) Graft-Vs-Host Disease (GVHD) Prophylaxis Significantly Abrogates Pre-Engraftment Syndrome (PES) & Severe Acute Gvhd after Adult Double Unit Cord Blood Transplantation (dCBT) Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.100 |
0.428 |
|
| 2020 |
Jansen SA, Hoesel Mv, Mokry M, Sierra LS, Takashima S, Nieuwenhuis EE, Hanash AM, Lindemans CA. Chemotherapy and Inflammation Induced Damage of Intestinal Epithelium Is Associated with Increased T Cell Chemotaxis Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.025 |
0.508 |
|
| 2019 |
Takashima S, Martin ML, Jansen SA, Fu Y, Bos J, Chandra D, O'Connor MH, Mertelsmann AM, Vinci P, Kuttiyara J, Devlin SM, Middendorp S, Calafiore M, Egorova A, Kleppe M, ... ... Hanash AM, et al. T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage. Science Immunology. 4. PMID 31811055 DOI: 10.1126/Sciimmunol.Aay8556 |
0.526 |
|
| 2019 |
Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, ... ... Hanash AM, et al. Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplant. The Journal of Clinical Investigation. PMID 31689242 DOI: 10.1172/Jci121127 |
0.514 |
|
| 2019 |
Fu YY, Egorova A, Sobieski C, Kuttiyara J, Calafiore M, Takashima S, Clevers H, Hanash AM. T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation. Immunity. PMID 31278057 DOI: 10.1016/J.Immuni.2019.06.003 |
0.543 |
|
| 2019 |
Vinci P, Hanash AM. BCL6 inhibition: a chronic GVHD twofer. Blood. 133: 4-5. PMID 30606808 DOI: 10.1182/Blood-2018-11-879692 |
0.435 |
|
| 2019 |
Takashima S, Martin ML, Jansen SA, Fu Y, Egorova A, Liu C, Kolesnick R, Lindemans CA, Hanash AM. T-Cell Derived Interferon Gamma Directly Targets Intestinal Epithelium to Induce Stem Cell Apoptosis in GI Gvhd Blood. 134: 585-585. DOI: 10.1182/Blood-2019-130811 |
0.524 |
|
| 2019 |
Vinci P, Garcia-Martinez E, O'Connor MH, Egorova A, Kuttiyara J, Arnhold V, Ponce DM, Hanash AM. Graft Versus Host Disease Leads to Elimination of Tissue-Resident Innate Lymphoid Cells Following Experimental and Clinical Allogeneic Transplantation Blood. 134: 3204-3204. DOI: 10.1182/Blood-2019-128966 |
0.461 |
|
| 2019 |
Flores NC, Politikos I, Maloy MA, Naputo K, Hanash AM, Peled JU, Brink MRMvd, Ponce DM, Barker JN. An Analysis of the Correlation between Gastro-Intestinal (GI) Symptoms, Macroscopic Appearance, Histology & Acute Gvhd (aGVHD) Treatment Responses in Cord Blood Transplant (CBT) Recipients: Significant Implications for aGVHD Management Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.219 |
0.339 |
|
| 2019 |
Politikos I, Maloy MA, Devlin SM, Naputo K, Bhatt V, Cho C, Giralt SA, Gyurkocza B, Hanash AM, Papadopoulos EB, Peled JU, Tamari R, Ponce DM, Barker JN. Addition of Tocilizumab to Cyclosporine/ MMF for Acute Graft-Vs-Host Disease (aGVHD) Prophylaxis in Adult Double Unit Cord Blood Transplant (dCBT) Recipients: Promising Preliminary Results of a Phase II Clinical Trial. Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.216 |
0.337 |
|
| 2019 |
Vinci P, Garcia-Martinez E, O'Connor MH, Egorova A, Mertelsmann AM, Nicoletti E, Geary CD, Devlin SM, Brink MRMvd, Jenq RR, Hanash AM. Graft-Versus-Host Disease Leads to Systemic Elimination of Innate Lymphoid Cells and Abolishes Their Development Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.098 |
0.527 |
|
| 2018 |
Tsai JJ, Velardi E, Shono Y, Argyropoulos KV, Holland AM, Smith OM, Yim NL, Rao UK, Kreines FM, Lieberman SR, Young LF, Lazrak A, Youssef S, Fu YY, Liu C, ... ... Hanash AM, et al. Nrf2 regulates CD4 T cell-induced acute graft-versus-host disease in mice. Blood. PMID 30381375 DOI: 10.1182/Blood-2017-10-812941 |
0.583 |
|
| 2018 |
Campbell C, Dikiy S, Bhattarai SK, Chinen T, Matheis F, Calafiore M, Hoyos B, Hanash A, Mucida D, Bucci V, Rudensky AY. Extrathymically Generated Regulatory T Cells Establish a Niche for Intestinal Border-Dwelling Bacteria and Affect Physiologic Metabolite Balance. Immunity. PMID 29858010 DOI: 10.1016/J.Immuni.2018.04.013 |
0.435 |
|
| 2018 |
Wertheimer T, Velardi E, Tsai J, Cooper K, Xiao S, Kloss CC, Ottmüller KJ, Mokhtari Z, Brede C, deRoos P, Kinsella S, Palikuqi B, Ginsberg M, Young LF, Kreines F, ... ... Hanash AM, et al. Production of BMP4 by endothelial cells is crucial for endogenous thymic regeneration. Science Immunology. 3. PMID 29330161 DOI: 10.1126/Sciimmunol.Aal2736 |
0.355 |
|
| 2018 |
Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulos KV, Jae-Hung S, Young LF, Lazrak A, Smith OM, Lieberman S, Kreines F, Shono Y, Wertheimer T, Jenq RR, Hanash AM, et al. Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury. Nature Medicine. PMID 29309056 DOI: 10.1038/Nm.4470 |
0.352 |
|
| 2018 |
Takashima S, Bos J, Chandra D, Jansen SA, O'Connor M, Mertelsmann AM, Calafiore M, Egorova A, Lo Y, Shroyer NF, Lindemans CA, Hanash AM. Interferon-γ Mediates Direct Intestinal Stem Cell Damage in Gastrointestinal Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.639 |
0.458 |
|
| 2018 |
Fu Y, Egorova A, Sobieski C, Calafiore M, Clevers H, Hanash AM. The Intestinal Stem Cell Compartment is the Initial Target of T Cell Invasion in GI Gvhd Biology of Blood and Marrow Transplantation. 24: S67. DOI: 10.1016/J.Bbmt.2017.12.638 |
0.473 |
|
| 2018 |
Bhatt V, Politikos I, Devlin SM, Jacob AG, Maloy M, Naputo K, Afuye A, Scaradavou A, O'Reilly RJ, Castro-Malaspina H, Dahi PB, Giralt SA, Gyurkocza B, Jakubowski AA, Papadopoulos EB, ... ... Hanash AM, et al. Therapeutic Cyclosporine-a (CSA) Levels in the First 7 Days after Cord Blood Transplantation (CBT) Are Critical to Prevent Severe Acute Graft-Versus-Host Disease (aGVHD) Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.298 |
0.422 |
|
| 2018 |
Tsai JJ, Velardi E, Shono Y, Argyropoulos K, Smith OM, Lazrak A, Liu C, Murphy GF, Fu Y, Hanash AM, Jenq RR, Dudakov JA, van den Brink MR. Nrf2 is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 24: S175-S176. DOI: 10.1016/J.Bbmt.2017.12.126 |
0.503 |
|
| 2017 |
Takashima S, Hanash AM. The enteric virome in hematopoietic stem cell transplantation: ready for its close-up. Nature Medicine. 23: 1012-1013. PMID 28886006 DOI: 10.1038/Nm.4403 |
0.475 |
|
| 2017 |
Dudakov JA, Mertelsmann AM, O'Connor MH, Jenq RR, Velardi E, Young LF, Smith OM, Boyd RL, van den Brink MRM, Hanash AM. Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft vs. host disease. Blood. PMID 28607133 DOI: 10.1182/Blood-2017-01-762658 |
0.551 |
|
| 2017 |
Fischer JC, Bscheider M, Eisenkolb G, Lin CC, Wintges A, Otten V, Lindemans CA, Heidegger S, Rudelius M, Monette S, Porosnicu Rodriguez KA, Calafiore M, Liebermann S, Liu C, Lienenklaus S, ... ... Hanash AM, et al. RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury. Science Translational Medicine. 9. PMID 28424327 DOI: 10.1126/Scitranslmed.Aag2513 |
0.402 |
|
| 2017 |
Ghosh A, Smith M, James SE, Davila ML, Velardi E, Argyropoulos KV, Gunset G, Perna F, Kreines FM, Levy ER, Lieberman S, Jay HV, Tuckett AZ, Zakrzewski JL, Tan L, ... ... Hanash AM, et al. Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity. Nature Medicine. PMID 28067900 DOI: 10.1038/Nm.4258 |
0.565 |
|
| 2016 |
Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Hematology. American Society of Hematology. Education Program. 2016: 119-127. PMID 27913470 DOI: 10.1182/Asheducation-2016.1.119 |
0.421 |
|
| 2016 |
Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood. 128: 2395-2402. PMID 27856471 DOI: 10.1182/Blood-2016-06-716738 |
0.421 |
|
| 2016 |
Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, et al. Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nature Immunology. 17: 1235. PMID 27648549 DOI: 10.1038/Ni1016-1235B |
0.376 |
|
| 2016 |
Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, ... ... Hanash AM, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Science Translational Medicine. 8: 339ra71. PMID 27194729 DOI: 10.1126/Scitranslmed.Aaf2311 |
0.44 |
|
| 2016 |
Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nature Immunology. PMID 26998764 DOI: 10.1038/Ni.3400 |
0.457 |
|
| 2016 |
Velardi E, Tsai JJ, Argyropoulos KV, Jae-Hung S, Lieberman S, Kreines F, Shono Y, Young L, Wertheimer T, Jenq RR, Hanash AM, Moore MAS, Brink MVD, Dudakov JA. Suppression of Luteinizing Hormone Enhances HSC Recovery after Hematopoietic Injuries Blood. 128: 370-370. DOI: 10.1182/Blood.V128.22.370.370 |
0.352 |
|
| 2016 |
Getta BM, Ghosh A, Coombs CC, Devlin S, Arcila M, Mohanty A, Levine RL, Tallman MS, Jakubowski AA, Giralt SA, Hanash AM. TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant Blood. 128: 3481-3481. DOI: 10.1182/Blood.V128.22.3481.3481 |
0.32 |
|
| 2016 |
Bhatt V, Palazzo M, Kilroy K, Hilden P, Devlin SM, Maloy M, Barker JN, Castro-Malaspina H, Chung DJ, Dahi P, Hsu KC, Hanash AM, Jakubowski AA, Jenq R, Koehne G, et al. Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Feasible Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) after Myeloablative Adult Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.740 |
0.418 |
|
| 2016 |
Lindemans CA, Calafiore M, O'Connor M, Mertelsmann A, Brink MRMvd, Hanash AM. Interleukin-22 Treatment Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration Via Stat3 Activation and Reduces GI Gvhd Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.345 |
0.411 |
|
| 2015 |
Barker J, Hanash A. Cord blood T cells are "completely different", Blood. 126: 2778-2779. PMID 26705344 DOI: 10.1182/Blood-2015-11-675504 |
0.369 |
|
| 2015 |
Lindemans CA, Calafiore M, Mertelsmann AM, O'Connor MH, Dudakov JA, Jenq RR, Velardi E, Young LF, Smith OM, Lawrence G, Ivanov JA, Fu YY, Takashima S, Hua G, Martin ML, ... ... Hanash AM, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. PMID 26649819 DOI: 10.1038/Nature16460 |
0.429 |
|
| 2015 |
Hanash AM. Does GVHD make amateurs out of professional APCs? Blood. 126: 1404-5. PMID 26384284 DOI: 10.1182/Blood-2015-07-657163 |
0.43 |
|
| 2015 |
Purtill D, Stevens CE, Lubin M, Ponce D, Hanash A, Giralt S, Scaradavou A, Young JW, Barker JN. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26211983 DOI: 10.1016/J.Bbmt.2015.07.015 |
0.439 |
|
| 2015 |
Jenq R, Taur Y, Devlin S, Ponce D, Goldberg J, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross J, Peets TK, ... ... Hanash AM, et al. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 25977230 DOI: 10.1016/J.Bbmt.2015.04.016 |
0.409 |
|
| 2015 |
Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annual Review of Immunology. 33: 747-85. PMID 25706098 DOI: 10.1146/Annurev-Immunol-032414-112123 |
0.386 |
|
| 2015 |
Harnicar S, Ponce DM, Hilden P, Zheng J, Devlin SM, Lubin M, Pozotrigo M, Mathew S, Adel N, Kernan NA, O'Reilly R, Prockop S, Scaradavou A, Hanash A, Jenq R, et al. Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 920-5. PMID 25687796 DOI: 10.1016/J.Bbmt.2015.01.024 |
0.391 |
|
| 2015 |
Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S, Goldberg JD, Hanash A, Hsu K, Jenq R, Perales MA, Sauter C, van den Brink MR, Young JW, Brentjens R, et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 125: 199-205. PMID 25377785 DOI: 10.1182/Blood-2014-06-584789 |
0.404 |
|
| 2015 |
Bhatt V, Palazzo M, Kilroy K, Hilden P, Maloy M, Barker JN, Castro-Malaspina HR, Chung DJ, Dahi PB, Hsu KC, Hanash AM, Jakubowski AA, Jenq RR, Koehne G, Landau H, et al. Low Dose Unfractionated Heparin (UFH) Prophylaxis Is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome (SOS) in Adult Allogeneic Stem Cell Transplant (HSCT) Recipients Blood. 126: 4332-4332. DOI: 10.1182/Blood.V126.23.4332.4332 |
0.361 |
|
| 2015 |
Fischer JC, Bscheider M, Eisenkolb G, Wintges A, Lindemans CA, Heidegger S, Monette S, Calafiore M, Rodriguez KAP, Lieberman S, Liu C, Peschel C, Docampo M, Velardi E, Jenq RR, ... Hanash AM, et al. RIG-I-Induced Type I IFNs Promote Regeneration of the Intestinal Stem Cell Compartment during Acute Tissue Damage Blood. 126: 3072-3072. DOI: 10.1182/Blood.V126.23.3072.3072 |
0.457 |
|
| 2015 |
Ponce DM, Devlin S, Bhatt V, Pozotrigo M, Lubin M, Lauer E, Kernan NA, Scaradavou A, Hanash AM, Perales M, Brink MRMvd, Young JW, Giralt S, Barker J. In Landmark Analysis the Severity of Day 100 Acute Graft-Versus-Host Disease (aGVHD) Has No Impact on Long-Term Progression-Free Survival (PFS) after Double-Unit Cord Blood Transplantation (DCBT) Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.551 |
0.397 |
|
| 2015 |
Lindemans CA, Mertelsmann A, O'Connor M, Calafiore M, Dudakov JA, Jenq R, Velardi E, Young L, Smith OM, Lawrence G, Luo N, Ivanov J, Hua G, Martin L, Liu C, ... ... Hanash AM, et al. IL-22 Directly Regulates Intestinal Stem Cells, Protecting Epithelium from GvHD and Reducing GvHD Mortality Biology of Blood and Marrow Transplantation. 21: S58-S59. DOI: 10.1016/J.Bbmt.2014.11.058 |
0.426 |
|
| 2014 |
Geiger TL, Abt MC, Gasteiger G, Firth MA, O'Connor MH, Geary CD, O'Sullivan TE, van den Brink MR, Pamer EG, Hanash AM, Sun JC. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. The Journal of Experimental Medicine. 211: 1723-31. PMID 25113970 DOI: 10.1084/Jem.20140212 |
0.393 |
|
| 2014 |
Lindemans CA, Hanash AM. The importance of bone marrow involvement in GVHD. Blood. 124: 837-8. PMID 25104865 DOI: 10.1182/Blood-2014-06-576991 |
0.43 |
|
| 2014 |
Lindemans CA, Mertelsmann A, O'Connor MH, Dudakov JA, Jenq R, Velardi E, Young LF, Smith OM, Lawrence G, Luo N, Ivanov J, Hua G, Martin ML, Liu C, Kolesnick R, ... ... Hanash AM, et al. IL-22 Is an Intestinal Stem Cell Growth Factor, and IL-22 Administration in Vivo Reduces Morbidity and Mortality in Murine GvHD Blood. 124: 651-651. DOI: 10.1182/Blood.V124.21.651.651 |
0.435 |
|
| 2014 |
Fischer JC, Lindemans CA, Lin C, Wintges A, Bscheider M, Wertheimer T, Heidegger S, Jenq R, Dudakov JA, Hanash AM, Peschel C, Haas T, Brink MRMvd, Poeck H. The Role of the Cytoplasmic RNA Sensor Retinoic Acid Inducible Gene- I (RIG-I) in Allogeneic Stem Cell Transplantation Blood. 124: 3827-3827. DOI: 10.1182/Blood.V124.21.3827.3827 |
0.492 |
|
| 2014 |
Lindemans C, Mertelsmann A, Dudakov JA, Velardi E, Hua G, O'Connor M, Kolesnick R, van den Brink MR, Hanash AM. IL-22 Administration Protects Intestinal Stem Cells from Gvhd Biology of Blood and Marrow Transplantation. 20: S53-S54. DOI: 10.1016/J.Bbmt.2013.12.056 |
0.415 |
|
| 2013 |
Ghosh A, Holland AM, Dogan Y, Yim NL, Rao UK, Young LF, West ML, Singer NV, Lee H, Na IK, Tsai JJ, Jenq RR, Penack O, Hanash AM, Lezcano C, et al. PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD. Cancer Research. 73: 4687-96. PMID 23733752 DOI: 10.1158/0008-5472.Can-12-4699 |
0.525 |
|
| 2013 |
Ghosh A, Dogan Y, Moroz M, Holland AM, Yim NL, Rao UK, Young LF, Tannenbaum D, Masih D, Velardi E, Tsai JJ, Jenq RR, Penack O, Hanash AM, Smith OM, et al. Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity. The Journal of Clinical Investigation. 123: 2654-62. PMID 23676461 DOI: 10.1172/Jci66301 |
0.534 |
|
| 2013 |
Tsai JJ, Dudakov JA, Takahashi K, Shieh JH, Velardi E, Holland AM, Singer NV, West ML, Smith OM, Young LF, Shono Y, Ghosh A, Hanash AM, Tran HT, Moore MA, et al. Nrf2 regulates haematopoietic stem cell function. Nature Cell Biology. 15: 309-16. PMID 23434824 DOI: 10.1038/Ncb2699 |
0.363 |
|
| 2013 |
Ponce DM, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S, Goldberg JD, Hanash AM, Jakubowski A, Jenq R, Papadopoulos EB, Perales MA, van den Brink MR, Young JW, Boulad F, O'Reilly RJ, et al. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 904-11. PMID 23416854 DOI: 10.1016/J.Bbmt.2013.02.008 |
0.444 |
|
| 2013 |
Hartrampf S, Dudakov JA, Johnson LK, Smith OM, Tsai J, Singer NV, West ML, Hanash AM, Albert MH, Liu B, Toth M, van den Brink MR. The central nervous system is a target of acute graft versus host disease in mice. Blood. 121: 1906-10. PMID 23299314 DOI: 10.1182/Blood-2012-09-456590 |
0.532 |
|
| 2013 |
Mertelsmann AM, Dudakov JA, Velardi E, Hua G, Kreines FM, Levy ER, O'Connor M, Smith OM, Kolesnick R, van den Brink MRM, Hanash AM. IL-22 Administration Decreases Intestinal Gvhd Pathology, Increases Intestinal Stem Cell Recovery, and Enhances Immune Reconstitution Following Allogeneic Hematopoietic Transplantation Blood. 122: 290-290. DOI: 10.1182/Blood.V122.21.290.290 |
0.525 |
|
| 2013 |
Dudakov JA, Cole D, Hanash AM, Young LF, Kreines FM, Levy ER, Smith OM, Velardi E, Brink Mvd. Intrathymic Innate Lymphoid Cells: Long-Lived Mediators Of Immune Regeneration Blood. 122: 289-289. DOI: 10.1182/Blood.V122.21.289.289 |
0.46 |
|
| 2013 |
Hanash AM, Devlin SM, Maloy M, Knapp KM, Miller VA, Lipson D, Stephens PJ, Otto GA, Yelensky R, Nahas MK, Wang K, Levine RL, van den Brink MR, Jakubowski AA. Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation Blood. 122: 2096-2096. DOI: 10.1182/Blood.V122.21.2096.2096 |
0.311 |
|
| 2013 |
Du Rocher B, Smith OM, Intlekofer AM, Dudakov JA, Levy E, Kreiners F, Reiner S, Abdelhay E, van den Brink MR, Hanash AM. Eomesodermin Regulates The Early Activation Of Alloreactive CD4 T Cells and Is Critical For Both Gvh and GVL Responses Blood. 122: 133-133. DOI: 10.1182/Blood.V122.21.133.133 |
0.535 |
|
| 2012 |
Holland AM, Zakrzewski JL, Tsai JJ, Hanash AM, Dudakov JA, Smith OM, West ML, Singer NV, Brill J, Sun JC, van den Brink MR. Extrathymic development of murine T cells after bone marrow transplantation. The Journal of Clinical Investigation. 122: 4716-26. PMID 23160195 DOI: 10.1172/Jci60630 |
0.517 |
|
| 2012 |
Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, Ghosh A, Tsai JJ, Rao UK, Yim NL, Smith OM, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 37: 339-50. PMID 22921121 DOI: 10.1016/J.Immuni.2012.05.028 |
0.471 |
|
| 2012 |
Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, Liu C, West ML, Singer NV, Equinda MJ, Gobourne A, Lipuma L, Young LF, Smith OM, Ghosh A, ... Hanash AM, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. The Journal of Experimental Medicine. 209: 903-11. PMID 22547653 DOI: 10.1084/Jem.20112408 |
0.434 |
|
| 2012 |
Hanash AM. MataHari reveals secrets of GVHD. Blood. 119: 3656-7. PMID 22517875 DOI: 10.1182/Blood-2012-01-394536 |
0.389 |
|
| 2012 |
Dudakov JA, Hanash AM, Jenq RR, Young LF, Ghosh A, Singer NV, West ML, Smith OM, Holland AM, Tsai JJ, Boyd RL, van den Brink MR. Interleukin-22 drives endogenous thymic regeneration in mice. Science (New York, N.Y.). 336: 91-5. PMID 22383805 DOI: 10.1126/Science.1218004 |
0.379 |
|
| 2012 |
Hanash AM, Van Den Brink MRM, Hua G, Kolesnick R, Blazar BR. Effect of IL-22 on intestinal stem cells, GVHD-related tissue damage, and GVL. Journal of Clinical Oncology. 30: 6539-6539. DOI: 10.1200/Jco.2012.30.15_Suppl.6539 |
0.469 |
|
| 2012 |
Ghosh A, Davila ML, Young LF, Kloss C, Gunset G, Smith OM, West ML, Singer NV, Holland AM, Jenq RR, Hanash AM, Dudakov JA, Velardi E, Shono Y, Sadelain M, et al. CD19-Targeted Donor T Cells Exert Potent Graft Versus Lymphoma Activity and Attenuated Gvhd Blood. 120: 451-451. DOI: 10.1182/Blood.V120.21.451.451 |
0.52 |
|
| 2012 |
Ponce DM, Gonzales AMR, Lubin MN, Castro-Malaspina HR, Giralt SA, Goldberg JD, Hanash AM, Jakubowski AA, Jenq RR, Papadopoulos EB, Perales M, Van Den Brink M, Young JW, Boulad F, O'Reilly RJ, et al. Graft-Versus-Host Disease After Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit Recipient HLA-Match Blood. 120: 4197-4197. DOI: 10.1182/Blood.V120.21.4197.4197 |
0.434 |
|
| 2012 |
Hanash AM, Dudakov JA, Hua G, O'Connor M, Young LF, Blazar BR, Kolesnick R, van den Brink MR. Innate Lymphoid Cell-Derived IL-22 Regulates Epithelial Recovery From Gvhd Blood. 120: 339-339. DOI: 10.1182/Blood.V120.21.339.339 |
0.497 |
|
| 2012 |
Dudakov JA, Hanash AM, Singer NV, West ML, Young LF, Jenq RR, Boyd RL, Brink MVD. Age-Related Thymic Involution Triggers Intrinsic Regeneration Pathways but They Remain Ineffective for Its Renewal Blood. 120: 1043-1043. DOI: 10.1182/Blood.V120.21.1043.1043 |
0.385 |
|
| 2012 |
Hanash A, Dudakov J, Hua G, O'Connor M, Jenq R, Holland A, Smith O, Liu C, Fouser L, Kolesnick R, Blazar B, van den Brink M. Host-Derived IL-22 Protects Intestinal Stem Cells from GVHD Biology of Blood and Marrow Transplantation. 18: S361-S362. DOI: 10.1016/J.Bbmt.2011.12.419 |
0.429 |
|
| 2012 |
Ghosh A, Dogan Y, Holland AM, Young LF, West ML, Singer NV, Smith OM, Jenq RR, Na I-, Penack O, Hanash AM, Sauer MG, Sadelain M, Brink MRMvd. Trail Over-Expression on Donor T Cells Enhances GVT and Suppresses GVHD by Inhibiting Alloreactive T Cells and Impairing Host APC Functions Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.416 |
0.488 |
|
| 2011 |
Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, et al. Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood. 118: 446-55. PMID 21596854 DOI: 10.1182/blood-2010-07-294785 |
0.496 |
|
| 2011 |
Ghosh A, Dogan Y, Holland AM, Smith OM, Young LF, West ML, Singer NV, Jenq RR, Na I, Penack O, Hanash AM, Sauer MG, Sadelain M, van den Brink MR. Over-Expression of TRAIL on Donor T Cells Enhances GVT and Suppresses Gvhd Via Elimination of Alloreactive T Cells and Host APC Blood. 118: 817-817. DOI: 10.1182/Blood.V118.21.817.817 |
0.539 |
|
| 2011 |
Hanash AM, Dudakov JA, Hua G, Young LF, O'connor M, Jenq RR, Holland AM, Smith OM, Liu C, Fouser L, Kolesnick R, Blazar BR, Van Den Brink M. Host-Derived IL-22 Limits Graft Versus Host Disease and Protects the Intestinal Stem Cell Niche Blood. 118: 309-309. DOI: 10.1182/Blood.V118.21.309.309 |
0.48 |
|
| 2011 |
Hartrampf S, Dudakov JA, Johnson LK, Smith OM, Tsai JJ, Hanash AM, Singer NV, West ML, Liu BF, Toth M, van den Brink MR. The Central Nervous System Is a Target Organ of Acute Graft-Versus-Host Disease Blood. 118: 1895-1895. DOI: 10.1182/Blood.V118.21.1895.1895 |
0.53 |
|
| 2011 |
Dudakov JA, Hanash AM, Young LF, Singer NV, West ML, Jenq RR, Smith OM, Holland AM, Boyd RL, Brink MRMvd. Innate Lymphoid Cell-Derived IL-22 Mediates Endogenous Thymic Repair Under the Control of IL-23 Blood. 118: 143-143. DOI: 10.1182/Blood.V118.21.143.143 |
0.353 |
|
| 2011 |
Ghosh A, Holland AM, Dogan Y, Yim N, Rao UK, Young LF, Smith OM, Jenq R, Na I, Tsai JJ, Singer N, West M, Penack O, Hanash AM, Sant'Angelo D, et al. Abstract 4743: Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD Cancer Research. 71: 4743-4743. DOI: 10.1158/1538-7445.Am2011-4743 |
0.514 |
|
| 2011 |
Tsai JJ, Tran H, Smith OM, Yim N, Rao U, Takahashi K, Ghosh A, Na I-, Jenq R, Hanash A, Holland A, Brink MRMvd. Nrf2 Regulates Alloreactive T Cell Function During GVHD Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.530 |
0.448 |
|
| 2011 |
Ghosh A, Holland AM, Dogan Y, Yim N, Rao UK, Young LF, Smith OM, Jenq R, Na I-, Tsai JJ, Singer N, West M, Penack O, Hanash AM, Sauer MG, et al. Genetically Engineered Donor T Cells for BMT Immunotherapy: Expression of Trail and PLZF Selectively Enhances GVT and Abrogates GVHD Biology of Blood and Marrow Transplantation. 17. DOI: 10.1016/J.Bbmt.2010.12.521 |
0.413 |
|
| 2010 |
van den Brink MR, Porter DL, Giralt S, Lu SX, Jenq RR, Hanash A, Bishop MR. Relapse after allogeneic hematopoietic cell therapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: S138-45. PMID 19857588 DOI: 10.1016/J.Bbmt.2009.10.023 |
0.438 |
|
| 2010 |
Ghosh A, Holland AM, Dogan Y, Yim N, Rao UK, Young LF, Smith OM, Jenq R, Na I, Tsai J, Penack O, Hanash AM, Sauer MG, Sant'Angelo D, Sadelain M, et al. Genetic Engineering of Donor T Cells for BMT Immunotherapy: Expression of TRAIL and PLZF Selectively Enhances GVT and Abrogates Gvhd Blood. 116: 730-730. DOI: 10.1182/Blood.V116.21.730.730 |
0.521 |
|
| 2010 |
Dudakov JA, Hanash AM, Rao UK, Holland AM, Jenq R, Goldberg GL, Boyd R, Brink MRMvd. Gvhd, Hematopoietic Dysfunction, and Post-Transplant Immune Deficiency: Loss of Marrow Function Leads to Ineffective Extramedullary Hematopoiesis, However Lymphoid Reconstitution Is Restored by the Synergistic Effects of KGF, Sex Steroid Ablation, and Precursor T Cell Adoptive Therapy. Blood. 116: 1468-1468. DOI: 10.1182/Blood.V116.21.1468.1468 |
0.553 |
|
| 2010 |
Ghosh A, Holland AM, Kappel LW, Dogan Y, Yim N, Rao U, Smith OM, Jenq RR, Zakrzewski J, Na I-, Lu S, Tsai J, Penack O, Hanash A, Sauer MG, et al. Over-Expression Of Trail On Donor T Cells Simultaneously Ameliorates GVHD And Enhances GVT Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.434 |
0.485 |
|
| 2006 |
Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 5460-5. PMID 16567639 DOI: 10.1073/Pnas.0509249103 |
0.614 |
|
| 2006 |
Hanash A, Jones A, Levy R. The role of MHC class II in CD4+CD25+ T cell-mediated facilitation of allogeneic hematopoietic engraftment and suppression of GVHD Biology of Blood and Marrow Transplantation. 12: 58. DOI: 10.1016/J.Bbmt.2005.11.181 |
0.564 |
|
| 2005 |
Hanash AM, Levy RB. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood. 105: 1828-36. PMID 15494429 DOI: 10.1182/Blood-2004-08-3213 |
0.673 |
|
| 2005 |
Murphy WJ, Bareo I, Hanash AM, Welniak LA, Sun K, Blazar BR, Levy RB. Suppression of NK Cell-Mediated Bone Marrow Cell Rejection by CD4+CD25+ Regulatory T Cells: Linkage of Adaptive to Innate Responses. Blood. 106: 2195-2195. DOI: 10.1182/Blood.V106.11.2195.2195 |
0.624 |
|
| 2005 |
Hanash A, Levy R. The requirement of MHC class II for donor CD4+CD25+ T cell-mediated support of early allogeneic progenitor cell engraftment Biology of Blood and Marrow Transplantation. 11: 30. DOI: 10.1016/J.Bbmt.2004.12.086 |
0.589 |
|
| 2004 |
Hanash A, Levy RB. Donor CD4+CD25+ T Cells Require Syngeneic MHC Class II for Initial Support of MHC-Mismatched Hematopoietic Engraftment. Blood. 104: 251-251. DOI: 10.1182/Blood.V104.11.251.251 |
0.627 |
|
| 2004 |
Hanash A, Levy R. Dissection of an MHC mismatched allogeneic transplant model during donor CD4+CD25+ T-cell facilitation of hematopoietic progenitors Biology of Blood and Marrow Transplantation. 10: 10-11. DOI: 10.1016/J.Bbmt.2003.12.030 |
0.612 |
|
| 2002 |
Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 588-96. PMID 12463477 DOI: 10.1053/Bbmt.2002.V8.Abbmt080588 |
0.645 |
|
| Show low-probability matches. |